Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-22

FDA Approved: CLOBAZAM — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approves CLOBAZAM as a generic clobazam product via an Original Application (ANDA) for Bionpharma Inc.; submission status is AP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

ORIG AP for CLOBAZAM (CLOBAZAM)